According to a new report from Intel Market Research, the global LNP-mRNA Therapy market was valued at USD 500 million in 2024 and is projected to reach USD 719 million by 2032, growing at a CAGR of 6.1% during the forecast period (2025–2032). This growth is propelled by the success of mRNA-based COVID-19 vaccines, increasing investments in...